chevron_leftBack
As of 5 June 2026, ToolGen Inc. has a market cap of $522.65M USD, ranking #14851 globally and #434 in South Korea.
It ranks #1323 in the Healthcare sector, and #270 in the Medical Devices industry.
Key Stats
Market Cap
$522.65MUSD
801.13B KRW
Enterprise Value
$504.1MUSD
772.7B KRW
Revenue (TTM)
$852.32KUSD
1.31B KRW
EBITDA (TTM)
-$14.04MUSD
-21.52B KRW
Net Income (TTM)
-$23.98MUSD
-36.76B KRW
PS Ratio
613.2
PB Ratio
14.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
Founded
1999
Website
toolgen.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.3% | -4.8% | 59% | 52% | 50% | 141% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
199800
(주)툴젠
ISIN: KR7199800004
Shares Out.:
Shares Outstanding:
8.995M1
Shares Float:
7.842M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
83,500 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About ToolGen Inc.
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 214150
|
$2.45B
368%
3.75T KRW
|
28.7
|
|
KRX: 458870
|
$1.22B
133%
1.86T KRW
|
114.8
|
|
KRX: 491000
|
$1.18B
126%
1.81T KRW
|
-
|
|
KRX: 290650
|
$1.13B
117%
1.74T KRW
|
-
|
|
KRX: 096530
|
$753.63M
44%
1.16T KRW
|
23.9
|
|
KRX: 214430
|
$528.2M
1.1%
809.64B KRW
|
83.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
33K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
31K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
30K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
24K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
23K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
19K%
|
22.2
|
chevron_leftBack